Sichuan Hebang Biotechnology Balance Sheet Health
Financial Health criteria checks 4/6
Sichuan Hebang Biotechnology has a total shareholder equity of CN¥19.6B and total debt of CN¥3.3B, which brings its debt-to-equity ratio to 16.9%. Its total assets and total liabilities are CN¥26.2B and CN¥6.6B respectively. Sichuan Hebang Biotechnology's EBIT is CN¥992.7M making its interest coverage ratio -20.2. It has cash and short-term investments of CN¥3.1B.
Key information
16.9%
Debt to equity ratio
CN¥3.32b
Debt
| Interest coverage ratio | -20.2x |
| Cash | CN¥3.06b |
| Equity | CN¥19.62b |
| Total liabilities | CN¥6.61b |
| Total assets | CN¥26.22b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603077's short term assets (CN¥11.1B) exceed its short term liabilities (CN¥5.7B).
Long Term Liabilities: 603077's short term assets (CN¥11.1B) exceed its long term liabilities (CN¥911.4M).
Debt to Equity History and Analysis
Debt Level: 603077's net debt to equity ratio (1.3%) is considered satisfactory.
Reducing Debt: 603077's debt to equity ratio has increased from 12.6% to 16.9% over the past 5 years.
Debt Coverage: 603077's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 603077 earns more interest than it pays, so coverage of interest payments is not a concern.